CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Revenue:
Total revenue	$ 10,052,248	$ 13,934,895
Cost of revenue:
Total cost of revenue	1,564,881	1,952,276
Gross profit	8,487,367	11,982,619
Operating expenses:
Research and development costs	2,561,825	2,833,643
Selling and marketing	4,003,764	5,672,023
General and administrative	3,178,604	2,887,957
Gain on litigation settlement	0	(632,600)
Restructuring costs	744	833,313
Total operating expenses	9,744,937	11,594,336
Operating income (loss)	(1,257,570)	388,283
Gain on debt extinguishment	0	754,000
Interest and other expense	(330,927)	(657,773)
Income (loss) before income taxes	(1,588,497)	484,510
Income tax expense	210,458	526,763
Net income (loss)	(1,798,955)	(42,253)
Less: Accrual of Series A redeemable convertible preferred stock dividends	1,494,057	1,143,697
Less: Accretion to redemption value of Series A redeemable convertible preferred stock	49,573	299,969
Net income (loss) attributable to common stockholders	$ (3,342,585)	$ (1,485,919)
Basic net income (loss) per share attributable to common stockholders	$ (0.47)	$ (0.23)
Diluted net income (loss) per share attributable to common stockholders	$ (0.47)	$ (0.23)
Weighted average basic shares outstanding	7,100,929	6,515,274
Weighted average diluted shares outstanding	7,100,929	6,515,274
Product Revenue
Revenue:
Total revenue	$ 4,246,177	$ 6,988,067
Cost of revenue:
Total cost of revenue	97,270	325,089
Support and Services Revenue
Revenue:
Total revenue	5,806,071	6,946,828
Cost of revenue:
Total cost of revenue	$ 1,467,611	$ 1,627,187